How to Cope with Allergies & Asthma in 2017

In 2017, Live Science is bringing our readers a monthly series on personal health goals, with tips and tricks we’ve gathered from the many health experts we’ve interviewed. Each month, we’ll focus on a different goal, and the goal for March is exercise.

Why asthmatics are less able to fight off flu

London, March 10 – People with asthma are likely to have worse symptoms when they get the flu and are more likely to end up in hospitals because of immune system differences, researchers said. The study showed that when exposed to the flu virus, people with asthma have weaker immune systems, whereas healthy people show a strong immune system-triggering reaction.

Why Men Are Much Worse At Being Sick Than Women

… Sabra Klein, associate professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health. “It isn’t always the presence of the microbe or the presence of the virus that makes us sick,” says Klein. “It’s our immune …

Bodywide immune response important for fighting cancer, Stanford researchers say

Fighting off cancer requires the concerted efforts of immune molecules throughout the body, rather than just in the tumor itself, according to a new study of laboratory mice by researchers at the Stanford University School of Medicine. The finding helps settle an ongoing dispute among clinicians as to whether systemic, or whole-body responses, are as important as a robust response by immune cells in the tumor itself.

Bodywide immune response important for fighting cancer, Stanford researchers say

Fighting off cancer requires the concerted efforts of immune molecules throughout the body, rather than just in the tumor itself, according to a new study of laboratory mice by researchers at the Stanford University School of Medicine. The finding helps settle an ongoing dispute among clinicians as to whether systemic, or whole-body responses, are as important as a robust response by immune cells in the tumor itself.

Asthma Diagnosis Later Reversed in About 1 in 3 Adults, Study Finds

Although asthma is considered a chronic disease, doctors have been puzzled by its often changing nature that can makes prescribing medicine, or stopping them, tricky. A study published Tuesday in the Journal of the American Medical Association found that about one-third of adults tested for the study, who had been diagnosed with asthma in the previous five years, showed no evidence of the condition during later follow-up examinations and testing.

Every meal triggers inflammation

When we eat, we do not just take in nutrients – we also consume a significant quantity of bacteria. The body is faced with the challenge of simultaneously distributing the ingested glucose and fighting these bacteria.

IsoPlexis Awarded Nih Sbir Grant to Develop Cellular Analysis Platform…

Alzheimer’s and other neurodegenerative diseases have tremendous unmet therapeutic and diagnostic need, and we are excited to be in a position to address these challenges with our platform. IsoPlexis Corporation , a venture-capital funded life sciences company developing an innovative cellular response analysis platform to measure the proteomic function of individual cells in patients, today announced it was recently awarded a competitive Phase I Small Business Innovation Research grant from the National Institute on Aging of the National Institutes of Health to develop a system to analyze trafficking leukocytes’ highly multiplexed proteomic responses in patients with Alzheimer’s disease.

Why More Women Get These Diseases Than Men

Nearly 80% of people who suffer from autoimmune diseases are women, and why that’s the case has long been a medical mystery. But new research suggests the answer may have to do with differences between men’s and women’s genes – a discovery that could pave the way for better diagnostic methods and treatments in the future.

Combination therapy holds great promise to clear precancerous skin lesions

A combination of two FDA-approved drugs – a topical chemotherapy and an immune-system-activating compound – was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment for this common skin condition, which can lead to the development of squamous cell carcinoma, takes up to a month and can elicit several unpleasant side effects.